Oxprenolol in hypertension: a report on 2,770 patients in general practice originally treated with methyldopa.

Substitution, in part of totally, of the non-selective beta-receptor antagonist oxprenolol for methyldopa in 2,770 treated hypertensive patients resulted in a significant reduction in blood pressure levels and a considerable improvement in the quality of the patient's life.